Cancerappy’s Post

Presenting 𝗚𝗲𝗻𝗶𝗮𝗹𝗶𝘀™ 𝗸𝗿𝗮𝘀𝗜𝗗: a new AI/ML classifier that accurately predicts KRAS outcomes in lung cancer patients. Have a look to learn more about our Early Access Program and to test drive the biomarker.💡 Download the poster by following the link in the comments.

Watch this short video to better understand Genialis's most recent breakthrough - 𝗚𝗲𝗻𝗶𝗮𝗹𝗶𝘀™ 𝗸𝗿𝗮𝘀𝗜𝗗: a classifier that accurately predicts outcomes in lung cancer patients!

At AACR24, we announced Genialis™ krasID  - a first-in-class biomarker that predicts response to and clinical benefit from KRAS inhibitors. Listen ⬇ to my colleagues Dr. Josh Wheeler and Prapti Koirala describe why Genialis™ krasID is different and how it can help you build a best-in-class KRAS drug. If you have a KRAS program, regardless of where you are in your clinical development journey, DM me regarding our Early Access Program. Stay updated via our website at genialis.com/krasid #kras #biomarker #RNA #cancer #precisiononcology #precisionmedicine Genialis

Studies of the effective use of AI in breast cancer screening ABs detection

Did you know that up to 80% of cancer diagnoses occur at the metastatic stage? Monitoring cancer therapy at this advanced stage can be challenging. Join Dr. Pravin D. Potdar as he shares insights into methods for circulating tumor cell (CTC) enumeration and isolation, as well as the importance of molecular profiling for diagnosing and monitoring metastatic cancers. Register for this on-demand webinar to stay informed about the latest advancements in cancer research!

Did you know that up to 80% of cancer diagnoses occur at the metastatic stage? Monitoring cancer therapy at this advanced stage can be challenging. Join Dr. Pravin D. Potdar as he shares insights into methods for circulating tumor cell (CTC) enumeration and isolation, as well as the importance of molecular profiling for diagnosing and monitoring metastatic cancers. Register for this on-demand webinar to stay informed about the latest advancements in cancer research!

Did you know that up to 80% of cancer diagnoses occur at the metastatic stage? Monitoring cancer therapy at this advanced stage can be challenging. Join Dr. Pravin D. Potdar as he shares insights into methods for circulating tumor cell (CTC) enumeration and isolation, as well as the importance of molecular profiling for diagnosing and monitoring metastatic cancers. Register for this on-demand webinar to stay informed about the latest advancements in cancer research!

Did you know that up to 80% of cancer diagnoses occur at the metastatic stage? Monitoring cancer therapy at this advanced stage can be challenging. Join Dr. Pravin D. Potdar as he shares insights into methods for circulating tumor cell (CTC) enumeration and isolation, as well as the importance of molecular profiling for diagnosing and monitoring metastatic cancers. Register for this on-demand webinar to stay informed about the latest advancements in cancer research!

Unlock your next cancer discovery with a multiomic strategy powered by #PacBio. Accurate long-read HiFi data empowers researchers to delve into the complete cancer genome, epigenome, and transcriptome using a single technology to unravel the complexities of cancer. Connect with us at #AACR24 to explore further: https://bit.ly/3xkJLXP Watch the full video here: https://bit.ly/3xkPiO3

🚀 Revolutionizing Personalized Cancer Treatment 🚀 Check out this summary of the blend between NGS and AI for personalized cancer treatment. This content is created by the outstanding IVPNeer and PM core team member Hind Haddadi.